Arlington Partners LLC Abb Vie Inc. Transaction History

Arlington Partners LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$137.6 - $154.97 $74,166 - $83,528	539 New	539 $83,000
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $102,165 - $127,137	-771 Reduced 16.14%	4,006 $539,000
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $370,780 - $427,008	2,564 Added 115.86%	4,777 $761,000
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $265,970 - $318,968	-1,923 Reduced 46.49%	2,213 $358,000
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $35,297 - $40,483	-263 Reduced 5.98%	4,136 $555,000
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $92,343 - $117,398	671 Added 18.0%	4,399 $674,000
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $27,287 - $34,526	254 Added 7.31%	3,728 $505,000
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $369,633 - $419,589	3,474 New	3,474 $375,000
Q3 2020 Oct 15, 2020	SELL	$85.91 - $100.83 $3,608 - $4,234	-42 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$73.37 - $98.18 $2,714 - $3,632	-37 Reduced 46.84%	42 $4,000
Q1 2020 Apr 13, 2020	BUY	$64.5 - $97.79 $5,095 - $7,725	79 New	79 $6,000
Q4 2018 Jan 10, 2019	SELL	$77.85 - $96.01 $78,005 - $96,202	-1,002 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$88.91 - $98.84 $89,087 - $99,037	1,002 New	1,002 $95,000

3,995

1.29B

18.2M

13.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.